These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26703860)

  • 1. A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.
    Tabah A; Cotta MO; Garnacho-Montero J; Schouten J; Roberts JA; Lipman J; Tacey M; Timsit JF; Leone M; Zahar JR; De Waele JJ
    Clin Infect Dis; 2016 Apr; 62(8):1009-1017. PubMed ID: 26703860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts.
    De Waele JJ; Schouten J; Beovic B; Tabah A; Leone M
    Intensive Care Med; 2020 Feb; 46(2):236-244. PubMed ID: 32025778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial De-Escalation in the ICU: From Recommendations to Level of Evidence.
    Lakbar I; De Waele JJ; Tabah A; Einav S; Martin-Loeches I; Leone M
    Adv Ther; 2020 Jul; 37(7):3083-3096. PubMed ID: 32462606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
    Daneman N; Sarwar S; Fowler RA; Cuthbertson BH;
    Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
    Tabah A; Bassetti M; Kollef MH; Zahar JR; Paiva JA; Timsit JF; Roberts JA; Schouten J; Giamarellou H; Rello J; De Waele J; Shorr AF; Leone M; Poulakou G; Depuydt P; Garnacho-Montero J
    Intensive Care Med; 2020 Feb; 46(2):245-265. PubMed ID: 31781835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance in intensive care units.
    Fridkin SK; Gaynes RP
    Clin Chest Med; 1999 Jun; 20(2):303-16, viii. PubMed ID: 10386258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for appropriate antibiotic use in intensive care unit.
    Silva CD; Silva Júnior M
    Einstein (Sao Paulo); 2015; 13(3):448-53. PubMed ID: 26132360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
    De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
    Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic stewardship in the intensive care unit.
    Luyt CE; Bréchot N; Trouillet JL; Chastre J
    Crit Care; 2014 Aug; 18(5):480. PubMed ID: 25405992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-driven antimicrobial stewardship in intensive care units in East China: A multicenter prospective cohort study.
    Li Z; Cheng B; Zhang K; Xie G; Wang Y; Hou J; Chu L; Zhao J; Xu Z; Lu Z; Sun H; Zhang J; Wang Z; Wu H; Fang X
    Am J Infect Control; 2017 Sep; 45(9):983-989. PubMed ID: 28596021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.
    Montravers P; Augustin P; Grall N; Desmard M; Allou N; Marmuse JP; Guglielminotti J
    Crit Care; 2016 Apr; 20():83. PubMed ID: 27052675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.
    De Bus L; Depuydt P; Steen J; Dhaese S; De Smet K; Tabah A; Akova M; Cotta MO; De Pascale G; Dimopoulos G; Fujitani S; Garnacho-Montero J; Leone M; Lipman J; Ostermann M; Paiva JA; Schouten J; Sjövall F; Timsit JF; Roberts JA; Zahar JR; Zand F; Zirpe K; De Waele JJ;
    Intensive Care Med; 2020 Jul; 46(7):1404-1417. PubMed ID: 32519003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.
    Schuts EC; Hulscher MEJL; Mouton JW; Verduin CM; Stuart JWTC; Overdiek HWPM; van der Linden PD; Natsch S; Hertogh CMPM; Wolfs TFW; Schouten JA; Kullberg BJ; Prins JM
    Lancet Infect Dis; 2016 Jul; 16(7):847-856. PubMed ID: 26947617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
    Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
    Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
    Kaye KS
    J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23737333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial de-escalation strategies in hospitalized patients with pneumonia, intra-abdominal infections, and bacteremia.
    Kaye KS
    J Hosp Med; 2012; 7 Suppl 1():S13-21. PubMed ID: 23677630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Empiric de-escalation strategy of antibiotic treatment].
    Adukauskiene D; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(9):703-8. PubMed ID: 17028467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.